CG Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	43.41	8.27	88.14	53.61
Short-Term Investments	497.3	179.41	55.34	-
Cash & Short-Term Investments	540.71	187.67	143.48	53.61
Cash Growth	276.85%	30.80%	167.65%	-
Other Receivables	0.14	0.09	0.3	0
Receivables	0.14	0.09	0.3	0
Prepaid Expenses	11.23	6.36	3.42	4.8
Total Current Assets	552.08	194.12	147.21	58.41
Property, Plant & Equipment	0.34	0.49	0.51	0.2
Long-Term Deferred Charges	-	4.67	-	-
Other Long-Term Assets	0.05	0.02	0.03	0.09
Total Assets	552.47	199.3	147.75	58.69
Accounts Payable	4.08	3.24	0.99	1
Accrued Expenses	11.11	9.68	5.12	1.89
Current Portion of Long-Term Debt	-	-	8.97	2.94
Current Portion of Leases	0.23	0.22	0.19	0.07
Other Current Liabilities	0.22	1.12	0.17	0.07
Total Current Liabilities	15.63	14.25	15.43	5.98
Long-Term Debt	-	-	6.53	12.06
Long-Term Leases	0.07	0.24	0.26	0.05
Other Long-Term Liabilities	-	0.01	0.35	0.35
Total Liabilities	15.7	14.51	22.57	18.44
Common Stock	0.01	-	-	0
Additional Paid-In Capital	722.95	6.84	3.64	3.27
Retained Earnings	-186.18	-129.94	-81.34	-45.89
Total Common Equity	536.77	-123.1	-77.69	-42.62
Shareholders' Equity	536.77	184.79	125.18	40.25
Total Liabilities & Equity	552.47	199.3	147.75	58.69
Total Debt	0.3	0.46	15.94	15.13
Net Cash (Debt)	540.41	187.21	127.54	38.48
Net Cash Growth	323.73%	46.79%	231.45%	-
Net Cash Per Share	11.62	43.23	34.09	10.54
Filing Date Shares Outstanding	67.63	66.64	3.84	3.65
Total Common Shares Outstanding	67.54	5.22	3.84	3.65
Working Capital	536.45	179.87	131.78	52.43
Book Value Per Share	7.95	-23.57	-20.22	-11.67
Tangible Book Value	536.77	-123.1	-77.69	-42.62
Tangible Book Value Per Share	7.95	-23.57	-20.22	-11.67

Source: S&P Capital IQ. Standard template. Financial Sources.